Ipilimumab vs Simvastatin

## Ipilimumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Simvastatin**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Simvastatin**: Prodrug converted to active form that inhibits HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Simvastatin — 2 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Simvastatin — C25H38O5.

**Molecular Weight**: Ipilimumab — N/A; Simvastatin — 418.5700 g/mol.

**Type**: Ipilimumab — Antibody; Simvastatin — Small molecule.